• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

report cover
  • 2 September 2020
  • Healthcare
  • 112 Pages
  • Report Code: 24LS-21380
  • Formate :   
Download FREE Report Sample Download PDF File

Influenza Vaccine -MARKET ADVISORY SERVICES

Influenza Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Influenza Vaccine market is segmented into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Segment by Application, the Influenza Vaccine market is segmented into
For Children (6 months to 3 years)
For Adults and Children over 3 years

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Influenza Vaccine Market Share Analysis
Influenza Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Influenza Vaccine product introduction, recent developments, Influenza Vaccine sales by region, type, application and by sales channel.

The major companies include:
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
...
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Influenza Vaccine Revenue 2015-2026
2.1.2 Global Influenza Vaccine Sales 2015-2026
2.2 Influenza Vaccine Market Size by Region: 2020 Versus 2026
2.3 Influenza Vaccine Sales by Region (2015-2026)
2.3.1 Global Influenza Vaccine Sales by Region: 2015-2020
2.3.2 Global Influenza Vaccine Sales Forecast by Region (2021-2026)
2.3.3 Global Influenza Vaccine Sales Market Share by Region (2015-2026)
2.4 Influenza Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Influenza Vaccine Revenue by Region: 2015-2020
2.4.2 Global Influenza Vaccine Revenue Forecast by Region (2021-2026)
2.4.3 Global Influenza Vaccine Revenue Market Share by Region (2015-2026)

3 Global Influenza Vaccine by Manufacturers
3.1 Global Top Influenza Vaccine Manufacturers by Sales
3.1.1 Global Influenza Vaccine Sales by Manufacturer (2015-2020)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Influenza Vaccine Revenue by Manufacturer (2015-2020)
3.2.2 Global Influenza Vaccine Revenue Share by Manufacturer (2015-2020)
3.3 Global Influenza Vaccine Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Influenza Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Influenza Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Influenza Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 CSL
4.1.1 CSL Corporation Information
4.1.2 CSL Description, Business Overview
4.1.3 CSL Influenza Vaccine Products Offered
4.1.4 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.1.5 CSL Influenza Vaccine Revenue by Product
4.1.6 CSL Influenza Vaccine Revenue by Application
4.1.7 CSL Influenza Vaccine Revenue by Geographic Area
4.1.8 CSL Influenza Vaccine Revenue by Sales Channel
4.1.9 CSL Recent Development
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Influenza Vaccine Products Offered
4.2.4 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.2.5 GSK Influenza Vaccine Revenue by Product
4.2.6 GSK Influenza Vaccine Revenue by Application
4.2.7 GSK Influenza Vaccine Revenue by Geographic Area
4.2.8 GSK Influenza Vaccine Revenue by Sales Channel
4.2.9 GSK Recent Development
4.3 Sanofi Pasteur
4.3.1 Sanofi Pasteur Corporation Information
4.3.2 Sanofi Pasteur Description, Business Overview
4.3.3 Sanofi Pasteur Influenza Vaccine Products Offered
4.3.4 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Sanofi Pasteur Influenza Vaccine Revenue by Product
4.3.6 Sanofi Pasteur Influenza Vaccine Revenue by Application
4.3.7 Sanofi Pasteur Influenza Vaccine Revenue by Geographic Area
4.3.8 Sanofi Pasteur Influenza Vaccine Revenue by Sales Channel
4.3.9 Sanofi Pasteur Recent Development
4.4 Mylan
4.4.1 Mylan Corporation Information
4.4.2 Mylan Description, Business Overview
4.4.3 Mylan Influenza Vaccine Products Offered
4.4.4 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Mylan Influenza Vaccine Revenue by Product
4.4.6 Mylan Influenza Vaccine Revenue by Application
4.4.7 Mylan Influenza Vaccine Revenue by Geographic Area
4.4.8 Mylan Influenza Vaccine Revenue by Sales Channel
4.4.9 Mylan Recent Development
4.5 AstraZeneca
4.5.1 AstraZeneca Corporation Information
4.5.2 AstraZeneca Description, Business Overview
4.5.3 AstraZeneca Influenza Vaccine Products Offered
4.5.4 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.5.5 AstraZeneca Influenza Vaccine Revenue by Product
4.5.6 AstraZeneca Influenza Vaccine Revenue by Application
4.5.7 AstraZeneca Influenza Vaccine Revenue by Geographic Area
4.5.8 AstraZeneca Influenza Vaccine Revenue by Sales Channel
4.5.9 AstraZeneca Recent Development
4.6 Pfizer
4.6.1 Pfizer Corporation Information
4.6.2 Pfizer Description, Business Overview
4.6.3 Pfizer Influenza Vaccine Products Offered
4.6.4 Pfizer Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Pfizer Influenza Vaccine Revenue by Product
4.6.6 Pfizer Influenza Vaccine Revenue by Application
4.6.7 Pfizer Influenza Vaccine Revenue by Geographic Area
4.6.8 Pfizer Recent Development
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Corporation Information
4.7.2 Johnson & Johnson Description, Business Overview
4.7.3 Johnson & Johnson Influenza Vaccine Products Offered
4.7.4 Johnson & Johnson Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Johnson & Johnson Influenza Vaccine Revenue by Product
4.7.6 Johnson & Johnson Influenza Vaccine Revenue by Application
4.7.7 Johnson & Johnson Influenza Vaccine Revenue by Geographic Area
4.7.8 Johnson & Johnson Recent Development
...

5 Breakdown Data by Type
5.1 Global Influenza Vaccine Sales by Type (2015-2026)
5.1.1 Global Influenza Vaccine Sales by Type (2015-2020)
5.1.2 Global Influenza Vaccine Sales Forecast by Type (2021-2026)
5.1.3 Global Influenza Vaccine Sales Market Share by Type (2015-2026)
5.2 Global Influenza Vaccine Revenue Forecast by Type (2015-2026)
5.2.1 Global Influenza Vaccine Revenue by Type (2015-2020)
5.2.2 Global Influenza Vaccine Revenue Forecast by Type (2021-2026)
5.2.3 Global Influenza Vaccine Revenue Market Share by Type (2015-2026)
5.3 Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Influenza Vaccine Sales by Application (2015-2026)
6.1.1 Global Influenza Vaccine Sales by Application (2015-2020)
6.1.2 Global Influenza Vaccine Sales Forecast by Application (2021-2026)
6.1.3 Global Influenza Vaccine Sales Market Share by Application (2015-2026)
6.2 Global Influenza Vaccine Revenue Forecast by Application (2015-2026)
6.2.1 Global Influenza Vaccine Revenue by Application (2015-2020)
6.2.2 Global Influenza Vaccine Revenue Forecast by Application (2021-2026)
6.2.3 Global Influenza Vaccine Revenue Market Share by Application (2015-2026)
6.3 Influenza Vaccine Average Selling Price (ASP) by Application (2015-2026)

7 North America
7.1 North America Influenza Vaccine Market Size YoY Growth 2015-2026
7.2 North America Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Influenza Vaccine Sales by Country (2015-2026)
7.2.2 North America Influenza Vaccine Revenue by Country (2015-2026)
7.3 North America Influenza Vaccine Sales by Type
7.4 North America Influenza Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccine Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Influenza Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Influenza Vaccine Sales by Region (2015-2026)
8.2.2 Asia-Pacific Influenza Vaccine Revenue by Region (2015-2026)
8.3 Asia-Pacific Influenza Vaccine Sales by Type
8.4 Asia-Pacific Influenza Vaccine Sales by Application
9 Europe
9.1 Europe Influenza Vaccine Market Size YoY Growth 2015-2026
9.2 Europe Influenza Vaccine Market Facts & Figures by Country
9.2.1 Europe Influenza Vaccine Sales by Country (2015-2026)
9.2.2 Europe Influenza Vaccine Revenue by Country (2015-2026)
9.3 Europe Influenza Vaccine Sales by Type
9.4 Europe Influenza Vaccine Sales by Application
10 Latin America
10.1 Latin America Influenza Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Influenza Vaccine Sales by Country (2015-2026)
10.2.2 Latin America Influenza Vaccine Revenue by Country (2015-2026)
10.3 Latin America Influenza Vaccine Sales by Type
10.4 Latin America Influenza Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Influenza Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Vaccine Sales by Country (2015-2026)
11.2.2 Middle East and Africa Influenza Vaccine Revenue by Country (2015-2026)
11.3 Middle East and Africa Influenza Vaccine Sales by Type
11.4 Middle East and Africa Influenza Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Influenza Vaccine Supply Chain Analysis
12.2 Influenza Vaccine Key Raw Materials and Upstream Suppliers
12.3 Influenza Vaccine Clients Analysis
12.4 Influenza Vaccine Sales Channel and Sales Model Analysis
12.4.1 Influenza Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Influenza Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Influenza Vaccine Distributors
13 Market Dynamics
13.1 Influenza Vaccine Market Drivers
13.2 Influenza Vaccine Market Opportunities
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables

Table 1. Global Influenza Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 2. Major Manufacturers of Whole Virus Vaccines

Table 3. Major Manufacturers of Split Virus Vaccines

Table 4. Major Manufacturers of Subunit Vaccines

Table 5. Major Manufacturers of Live Attenuated Virus Vaccines

Table 6. Global Influenza Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 7. Global Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2026

Table 8. Global Influenza Vaccine Sales by Region (2015-2020) & (K Doses)

Table 9. Global Influenza Vaccine Sales Forecast by Region (2021-2026) & (K Doses)

Table 10. Global Influenza Vaccine Revenue by Region (2015-2020) & (US$ Million)

Table 11. Global Influenza Vaccine Revenue Forecast by Region (2021-2026) & (US$ Million)

Table 12. Global Influenza Vaccine Sales by Manufacturer (2015-2020) & (K Doses)

Table 13. Global Influenza Vaccine Sales Share by Manufacturer (2015-2020)

Table 14. Influenza Vaccine Revenue by Manufacturer (2015-2020) & (US$ Million)

Table 15. Influenza Vaccine Revenue Share by Manufacturer (2015-2020)

Table 16. Key Manufacturers Influenza Vaccine Price (2015-2020) & (USD/Doses)

Table 17. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019

Table 18. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)

Table 19. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2019)

Table 20. Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Influenza Vaccine Product Type

Table 22. Date of International Manufacturers Enter into Influenza Vaccine Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. CSL Corporation Information

Table 25. CSL Description and Business Overview

Table 26. CSL Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 27. CSL Influenza Vaccine Product

Table 28. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 29. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 30. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 31. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 32. CSL Recent Development

Table 33. GSK Corporation Information

Table 34. GSK Description and Business Overview

Table 35. GSK Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 36. GSK Influenza Vaccine Product

Table 37. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 38. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 39. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 40. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 41. GSK Recent Development

Table 42. Sanofi Pasteur Corporation Information

Table 43. Sanofi Pasteur Description and Business Overview

Table 44. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 45. Sanofi Pasteur Influenza Vaccine Product

Table 46. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 47. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 48. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 49. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 50. Sanofi Pasteur Recent Development

Table 51. Mylan Corporation Information

Table 52. Mylan Description and Business Overview

Table 53. Mylan Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 54. Mylan Influenza Vaccine Product

Table 55. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 56. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 57. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 58. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 59. Mylan Recent Development

Table 60. AstraZeneca Corporation Information

Table 61. AstraZeneca Description and Business Overview

Table 62. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 63. AstraZeneca Influenza Vaccine Product

Table 64. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 65. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 66. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 67. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 68. AstraZeneca Recent Development

Table 69. Pfizer Corporation Information

Table 70. Pfizer Description and Business Overview

Table 71. Pfizer Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 72. Pfizer Influenza Vaccine Product

Table 73. Pfizer Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 74. Pfizer Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 75. Pfizer Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 76. Pfizer Recent Development

Table 77. Johnson & Johnson Corporation Information

Table 78. Johnson & Johnson Description and Business Overview

Table 79. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)

Table 80. Johnson & Johnson Influenza Vaccine Product

Table 81. Johnson & Johnson Influenza Vaccine Revenue (US$ Million) and Market Share by Product

Table 82. Johnson & Johnson Influenza Vaccine Revenue (US$ Million) and Market Share by Application

Table 83. Johnson & Johnson Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 84. Johnson & Johnson Recent Development

Table 85. Global Influenza Vaccine Sales by Type (2015-2020) & (K Doses)

Table 86. Global Influenza Vaccine Sales Forecast by Type (2021-2026) & (K Doses)

Table 87. Global Influenza Vaccine Revenue by Type (2015-2020) & (US$ Million)

Table 88. Global Influenza Vaccine Revenue Forecast by Type (2021-2026) & (US$ Million)

Table 89. Global Influenza Vaccine Sales by Application (2015-2020) & (K Doses)

Table 90. Global Influenza Vaccine Sales Forecast by Application (2021-2026) & (K Doses)

Table 91. Global Influenza Vaccine Revenue by Application (2015-2020) & (US$ Million)

Table 92. Global Influenza Vaccine Revenue Forecast by Application (2021-2026) & (US$ Million)

Table 93. North America Influenza Vaccine Sales by Country (2015-2020) & (K Doses)

Table 94. North America Influenza Vaccine Sales by Country (2021-2026) & (K Doses)

Table 95. North America Influenza Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 96. North America Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 97. North America Influenza Vaccine Sales by Type (2015-2020) & (K Doses)

Table 98. North America Influenza Vaccine Sales by Application (2015-2020) & (K Doses)

Table 99. Asia-Pacific Influenza Vaccine Sales by Region (2015-2020) & (K Doses)

Table 100. Asia-Pacific Influenza Vaccine Sales by Region (2021-2026) & (K Doses)

Table 101. Asia-Pacific Influenza Vaccine Revenue by Region (2015-2026) & (US$ Million)

Table 102. Asia-Pacific Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million)

Table 103. Asia-Pacific Influenza Vaccine Sales by Type (2015-2020) & (K Doses)

Table 104. Asia-Pacific Influenza Vaccine Sales by Application (2015-2020) & (K Doses)

Table 105. Europe Influenza Vaccine Sales by Country (2015-2020) & (K Doses)

Table 106. Europe Influenza Vaccine Sales by Country (2021-2026) & (K Doses)

Table 107. Europe Influenza Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 108. Europe Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 109. Europe Influenza Vaccine Sales by Type (2015-2020) & (K Doses)

Table 110. Europe Influenza Vaccine Sales by Application (2015-2020) & (K Doses)

Table 111. Latin America Influenza Vaccine Sales by Country (2015-2020) & (K Doses)

Table 112. Latin America Influenza Vaccine Sales by Country (2021-2026) & (K Doses)

Table 113. Latin America Influenza Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 114. Latin America Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 115. Latin America Influenza Vaccine Sales by Type (2015-2020) & (K Doses)

Table 116. Latin America Influenza Vaccine Sales by Application (2015-2020) & (K Doses)

Table 117. Middle East and Africa Influenza Vaccine Sales by Country (2015-2020) & (K Doses)

Table 118. Middle East and Africa Influenza Vaccine Sales by Country (2021-2026) & (K Doses)

Table 119. Middle East and Africa Influenza Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 120. Middle East and Africa Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 121. Middle East and Africa Influenza Vaccine Sales by Type (2015-2020) & (K Doses)

Table 122. Middle East and Africa Influenza Vaccine Sales by Application (2015-2020) & (K Doses)

Table 123. Influenza Vaccine Key Raw Materials, Industry Status and Trend

Table 124. Influenza Vaccine Key Raw Materials and Upstream Suppliers

Table 125. Influenza Vaccine Clients Status and Trend

Table 126. Influenza Vaccine Typical Clients

Table 127. Influenza Vaccine Distributors

Table 128. Key Drivers: Impact Analysis (2021-2026)

Table 129. Influenza Vaccine Market Drivers

Table 130. Influenza Vaccine Market Opportunities

Table 131. Influenza Vaccine Market Challenges

Table 132. Influenza Vaccine Market Restraints

Table 133. Influenza Vaccine Porter?s Five Forces Analysis

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

List of Figures

Figure 1. Influenza Vaccine Product Picture

Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2020 & 2026

Figure 3. Whole Virus Vaccines Product Picture

Figure 4. Split Virus Vaccines Product Picture

Figure 5. Subunit Vaccines Product Picture

Figure 6. Live Attenuated Virus Vaccines Product Picture

Figure 7. Global Influenza Vaccine Sales Market Share by Application in 2020 & 2026

Figure 8. For Children (6 months to 3 years) Examples

Figure 9. For Adults and Children over 3 years Examples

Figure 10. Influenza Vaccine Report Years Considered

Figure 11. Global Influenza Vaccine Market Size, (US$ Million), 2015 VS 2020 VS 2026

Figure 12. Global Influenza Vaccine Market Size 2015-2026 (US$ Million)

Figure 13. Global Influenza Vaccine Sales 2015-2026 (K Units)

Figure 14. Global Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Influenza Vaccine Sales Market Share Forecast by Region (2015-2026)

Figure 16. Global Influenza Vaccine Revenue Market Share by Region (2015-2026)

Figure 17. Global Influenza Vaccine Sales Share by Manufacturer in 2019

Figure 18. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 19. Global Influenza Vaccine Sales Market Share Forecast by Type (2015-2026)

Figure 20. Global Influenza Vaccine Revenue Market Share Forecast by Type (2015-2026)

Figure 21. Influenza Vaccine Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)

Figure 22. Global Influenza Vaccine Sales Market Share Forecast by Application (2015-2026)

Figure 23. Global Influenza Vaccine Revenue Market Share Forecast by Application (2015-2026)

Figure 24. Influenza Vaccine Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)

Figure 25. North America Influenza Vaccine Revenue 2015-2026 (US$ Million)

Figure 26. North America Influenza Vaccine Sales Market Share by Type (2015-2020)

Figure 27. North America Influenza Vaccine Sales Market Share by Application (2015-2020)

Figure 28. Asia-Pacific Influenza Vaccine Revenue 2015-2026 (US$ Million)

Figure 29. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2015-2026)

Figure 30. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2015-2026)

Figure 31. Asia-Pacific Influenza Vaccine Sales Market Share by Type (2015-2020)

Figure 32. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2015-2020)

Figure 33. Europe Influenza Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 34. Europe Influenza Vaccine Sales Market Share by Country (2015-2026)

Figure 35. Europe Influenza Vaccine Revenue Market Share by Country (2015-2026)

Figure 36. Europe Influenza Vaccine Sales Market Share by Type (2015-2020)

Figure 37. Europe Influenza Vaccine Sales Market Share by Application (2015-2020)

Figure 38. Latin America Influenza Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 39. Latin America Influenza Vaccine Sales Market Share by Country (2015-2026)

Figure 40. Latin America Influenza Vaccine Revenue Market Share by Country (2015-2020)

Figure 41. Latin America Influenza Vaccine Sales Market Share by Type (2015-2020)

Figure 42. Latin America Influenza Vaccine Sales Market Share by Application (2015-2020)

Figure 43. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 44. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2015-2026)

Figure 45. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2015-2026)

Figure 46. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2015-2020)

Figure 47. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2015-2020)

Figure 48. Influenza Vaccine Supply Chain (Upstream and Downstream Market)

Figure 49. Global Production Market Share of Influenza Vaccine Raw Materials by Region in 2019

Figure 50. Influenza Vaccine Distribution Channels

Figure 51. Global Influenza Vaccine Percentage 2015-2026: Indirect Sales VS Direct Sales

Figure 52. Global Influenza Vaccine Percentage 2015-2026: Online Sales VS Offline Sales

Figure 53. Porter's Five Forces Analysis

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

CSL

GSK

Sanofi Pasteur

Mylan

AstraZeneca

Pfizer

Johnson & Johnson

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $4602

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase